Melatonin 3 mg
Natural health product licensed in Canada
- Licence holder
- Holista Health (Canada) Inc.
- NPN or DIN-HM
- 80000830
- Status
- Active licence
- Licence date
- 21 September 2005
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Sublinguale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Cellulose, microcristalline, Stéarate de magnésium, Saveur de menthe poivrée, Lactose Monohydrate, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps increase total sleep time aspect of sleep quality in people suffering from sleep restriction or altered sleep phase schedule eg shift work and jet lag. Helps to reduce the time it takes to fall asleep in people with delayed sleep phase syndrome and to re-set the sleep-wake cycle of circadian rhythm.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a physician prior to use if you have a hormonal disorder, diabetes, liver or kidney disease, cerebral palsy, seizure disorders, migraine, depression and/or hypertension, or if you are taking blood pressure or sedative/hypnotic medications. Do not drive or use machinery for 5 hours after taking melatonin. If symptoms persist continuously for more than four weeks or if pain or other factors appear to be the cause of sleeplessness, consult your physician. Do not use if you are taking immunosupressive drugs and/or if pregnant or breastfeeding. Keep out of reach of children.
Source
Official Health Canada record, licence 80000830
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.